Gene therapy has the potential to change lives, slowing or stopping disease progression or even correcting symptoms entirely, ...

EMED Technologies Director of Clinical Affairs Alex Nikanorov shares the company’s approach to deciding which clinical ...

A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.

Discover Ocugen's Q1 2025 earnings insights, focusing on gene therapy advancements, key clinical trials, and financial updates.

Topcon Healthcare acquired RetInSight, an Austria-based company that develops AI-driven software for eye care professionals, ...

Artyc PBC, a leader in next-generation cold chain solutions for the modern healthcare industry, today announced the launch of the Medstow 5L Intercampus, a battery-powered, customizable cooler ...

Even after decades of research, there is no cure for the disease HIV causes, AIDS. But lenacapavir, born out of research on ...

MM120 ODT trials aim to address the unmet needs of over 50 million individuals in the U.S. alone, with a focus on delivering strong clinical outcomes for GAD and MDD. Management reiterated its ...

Q1 2025 Earnings Call Transcript May 7, 2025 Geron Corporation beats earnings expectations. Reported EPS is $-0.03, ...

The World Health Organization (WHO) has published the Global action plan for clinical trial ecosystem strengthening (GAP-CTS) ...

Research and Development (R&D) Expenses: R&D expense was $19.6 million for the first quarter of 2025, as compared to $12.5 ...

ASX medtechs are taking brain diagnostics beyond the hospital or clinical settings to the front lines of care for better ...